Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

BACKGROUND: In the last five years, countries have been faced with changing their malaria treatment policy to an artemisinin-based combination therapy (ACT), many with no national data on which to base their decision. This is particularly true for a number of West African countries, including Guinea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnet, Maryline, Roper, Cally, Félix, Martine, Coulibaly, Léonie, Kankolongo, Gabriel Mufuta, Guthmann, Jean Paul
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868032/
https://www.ncbi.nlm.nih.gov/pubmed/17477865
http://dx.doi.org/10.1186/1475-2875-6-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868032/
https://www.ncbi.nlm.nih.gov/pubmed/17477865
http://dx.doi.org/10.1186/1475-2875-6-54

Ejemplares similares